Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allocetra-OTS for Organ Failure in Adult Sepsis Patients
2021-003273-66Phase 2Suspended
- Sponsor
- Enlivex Therapeutics
- Start
- Jul 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial in sepsis comparing Allocetra-OTS dose-finding arms with Placebo control (2 arms). Primary endpoint: Change from baseline in SOFA score throughout 28 days. Started Jul 2021; status: suspended.
02
Drugs
Allocetra
03
Conditions
sepsis
Beyond the preview
Go deeper on 2021-003273-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003273-66.